Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $54.80 million. The enterprise value is $64.86 million.

Market Cap	54.80M
Enterprise Value	64.86M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, before market open.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.78 million shares outstanding. The number of shares has increased by 2.43% in one year.

Current Share Class	6.78M
Shares Outstanding	6.78M
Shares Change (YoY)	+2.43%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	8.81%
Owned by Institutions (%)	21.91%
Float	3.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.48
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 39.53, with a Debt / Equity ratio of 0.75.

Current Ratio	39.53
Quick Ratio	15.89
Debt / Equity	0.75
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.08

Financial Efficiency

Return on equity (ROE) is -50.39% and return on invested capital (ROIC) is -14.52%.

Return on Equity (ROE)	-50.39%
Return on Assets (ROA)	-14.16%
Return on Invested Capital (ROIC)	-14.52%
Return on Capital Employed (ROCE)	-26.63%
Weighted Average Cost of Capital (WACC)	9.36%
Revenue Per Employee	n/a
Profits Per Employee	-$5.10M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.73% in the last 52 weeks. The beta is 2.03, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	2.03
52-Week Price Change	-38.73%
50-Day Moving Average	8.53
200-Day Moving Average	15.14
Relative Strength Index (RSI)	39.53
Average Volume (20 Days)	26,496

Short Selling Information

The latest short interest is 328,526, so 4.84% of the outstanding shares have been sold short.

Short Interest	328,526
Short Previous Month	414,920
Short % of Shares Out	4.84%
Short % of Float	10.18%
Short Ratio (days to cover)	11.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-52.91M
Pretax Income	-71.37M
Net Income	-71.37M
EBITDA	-52.37M
EBIT	-52.91M
Earnings Per Share (EPS)	-$10.70

Full Income Statement

Balance Sheet

The company has $76.13 million in cash and $85.18 million in debt, giving a net cash position of -$9.05 million or -$1.33 per share.

Cash & Cash Equivalents	76.13M
Total Debt	85.18M
Net Cash	-9.05M
Net Cash Per Share	-$1.33
Equity (Book Value)	113.87M
Book Value Per Share	16.79
Working Capital	186.59M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-36.62M
Capital Expenditures	n/a
Depreciation & Amortization	534,000
Net Borrowing	n/a
Free Cash Flow	-36.62M
FCF Per Share	-$5.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.43%
Shareholder Yield	-2.43%
Earnings Yield	-127.87%
FCF Yield	-65.61%

Analyst Forecast

The average price target for Instil Bio is $125.00, which is 1,447.03% higher than the current price. The consensus rating is "Buy".

Price Target	$125.00
Price Target Difference	1,447.03%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2